>
 

Upcoming Presentations/Abstracts

ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA Daniel Goldstein MD, Yoshifumi Naka MD, Timothy Icenogle MD, Mark Slaughter MD, et al. "The Epidemiology of Bleeding and Clotting in Pulsatile and Continuous Flow LVAD Patients."(Accepted for Oral Presentation)
Platelet Activation in Patients Supported by Continuous Flow Left Ventricular Assist Devices. ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA Mark S Slaughter, MD, Michael A Sobieski, CCP, J. Graham, et al. "Cardiac Surgery Research and Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL, United States; Department of Biomedical Engineering, University of Louisville, Louisville, KY, United States; Laboratory Medicine & Pathology, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, United States and Division Hematology and Oncology, Advocate Christ Medical Center, Oak Lawn, IL, United States." (Accepted for Oral Presentation)
ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA Nutter AL, Slaughter MS, Silver MA. "A Decline in the VE/VCO2 Slope from Anaerobic Threshold to Peak Exercise Predicts Short Term Need for LVAD or Heart Transplant."(Accepted for Oral Presentation)
ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA Saba N Khan, MD, Chad M Feldman, MD, Mark S Slaughter, MD, et al. "Preferential Improvement in Exercise Time, Oxygen Consumption and Ventilatory Response in Patients Supported with Pneumatic versus Electric LVADs." (Accepted for Poster Presentation).
ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA Saba N Khan, MD, Chad M Feldman, MD, Mark S Slaughter, MD, et al. "Differential slopes of VE/VC02 at Anaerobic Threshold and Peak Exercise: A Possible Indicator of Myocardial Recovery with LVAD Support."(Accepted for Poster Presentation).
ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA Saba N Khan, MD, Timothy J Horrell, Joel D Graham, Michael A Sobieski, CCP, Marc Silver, MD and Mark S Slaughter, MD. "Hemocompatibility in Long Term LVAD Support: Continuous vs. Pulsatile Flow." (Accepted for Poster Presentation).

Tel. (630) 789-2296

Myocardial Assist Systems and Technology, LLC
314 Harris Avenue
Clarendon Hills, IL 60514

Publications & Presentations

Mark Slaughter, MD is not only an unsurpassed cardiothoracic surgeon, device researcher and developer, and active consultant, but often along with Michael Sobieski, he also shares his knowledge for advancing cardiac care with thousands of other professionals in the field through lectures, presentations, abstracts, books, and articles.

Lectures & Presentations | Books/Chapters | Published Articles

Recent Lectures & Presentations

The following is a select list of recent presentations by our team members.

  • Mark Slaughter: "Destination Therapy"
    ISHLT 28th Annual Meeting & Scientific Sessions, Boston, MA. April, 2008.
  • Mark Slaughter: "Partial Assist Pumps"
    Texas Heart Institute, Rodeo Meeting, Houston, TX. March 7-8, 2008.
  • Mark Slaughter: "Mechanical Circulatory Support for Congestive Heart Failure"
    Grand Rounds, University of Louisville, Louisville, KY. February 27, 2008.
  • Mark Slaughter: "Developing an LVAD Program"
    UCSF, Division of Cardiovascular Surgery, San Francisco, CA. Feb. 13-14, 2008.
  • Mark Slaughter: "Device Update on HeartMate II"
    EUMS – 2nd European Mechanical Circulatory Support Summit, Paris, France. November 30, 2007.
  • Mark Slaughter: "Permanent Mechanical Circulatory Support vs. Transplantation: Is the Difference Real or Artificial?"
    21st Century Treatment of Heart Failure: Synchronizing Surgical and Medical Therapies For Better Outcomes, AATS/ACC/Cleveland Clinic, Cleveland, OH. October 20, 2007.
  • Michael Sobieski: "Future Generation VADs: Perfusionist Perspective"
    The “Boston” Meeting & Hammersmith TFECC Filtration Workshop. Panel Presentation. Cambridge, MA. Oct 19-21, 2007.
  • Michael Sobieski: "Perfusion’s Role in Future VAD Technology"
    Illinois State Perfusion Society Annual Meeting. Oak Lawn, IL. Oct 12 – 14, 2007.
  • Mark S Slaughter, MD, Chad M Feldman, MD, Mark A Silver, MD, Michael A Sobieski, CCP, Pat Pappas, MD and Antone Tatooles, MD: "Low Incidence of Neurologic Events During Long-Term Support with Heartmate XVE"
    ASAIO 53rd Annual Conference. Chicago, IL. June 9, 2007.
  • S C Koenig, Phd, G A Giridharan, PhD, C Ionan, DVM, G M Pantalos, R D Dowling,MD, S Prabhu, MD, M A Sobieski, RN, M S Slaughter,MD: "Comparative Studies Between Human, Bovine, and Porcine Systemic Vascular Input Impedances"
    ASAIO 53rd Annual Conference.  Chicago, IL.  June 7, 2007.
  • Mark Slaughter, Michael Sobieski, Mark Silver, Pat Pappas, Antone Tatooles: "Effect of Heartmate II and Continuous Flow on the Fibrinolytic System"
    ASAIO 53rd Annual Conference.  Chicago, IL   June 7, 2007.
  • Michael Sobieski: "Hospital to Home"
    Economic Summit for Ventricular Assist Devices. Creating a Quality VAD Program with Sound Economic Practices. Burlington, MA. May 10-11, 2007.
  • Mark Slaughter: "Building a Destination Therapy Practice"
    ISHLT. San Francisco, CA. April 25-28, 2007.
  • Michael Sobieski: "Ventricular Assist Device Therapy"
    Guest Lecture. Midwestern University. Glendale, AZ. April 6, 2007.
  • Michael Sobieski: "ECHO and VAD’s, What Are We Looking For?"
    Advocate Christ Medical Center. Department of Cardiovascular Services. Grand Rounds. March 1, 2007.
  • Michael Sobieski: "Modern/Future Responsibilities of the Perfusionist"
    Special Scientific Session. 29th Annual Seminar on Cardiovascular Perfusion. American Academy of Cardiovascular Perfusion. Orlando, FL. January 27, 2007.
  • Michael Sobieski: "Fireside Chat: Ventricular Assist Devices"
    29th Annual Seminar on Cardiovascular Perfusion. American Academy of Cardiovascular Perfusion. Orlando, FL. January 25, 2007
  • Mark Slaughter: "Destination Therapy Improved Outcomes with HeartMate II LVAD"
    European Mechanical Circulatory Support Summit. Bad Oeynhausen, Germany. December 6-9, 2006.
  • Mark Slaughter: "Destination Therapy in Non-Transplant Hospitals: Why, When & How"
    21st Century Treatment of Heart Failure: Synchronizing Surgical and Medical Therapies for Better Outcomes. Cleveland, OH. October 21, 2006.
  • Mark Slaughter: "Mechanical Heart Replacement: Ready for Prime Time"
    Midwest Heart Foundation, Congestive Heart Failure Symposium. Lake Geneva, WI. September 15-16, 2006.
  • Mark Slaughter: "Reducing Emboli in Cardiac Surgery: Does it Make a Difference?"
    16th World Congress of the World Society of Cardiothoracic Surgeons. Ottawa, Canada. August 19, 2006.
Back to Top

Books/Book Chapters
  • Pagani FD, Russell SD, Moore S, Slaughter MS, Klodell C, Idrissi KA, Vay D. Patient Management Guidelines for the HeartMate II® LVAS. © 2007 Thoratec Corporation (Volume 1, February 2007)
  • Slaughter MS, Sobieski, MA, Cohn, L. "Cardiopulmonary Bypass: Techniques and Management."Cardiac Surgery in Chronic Renal Failure: Patient Management and Clinical Outcomes. © 2007 Blackwell Publishing Ltd., Oxford, UK/Future Publishing, Armonk, NY.
  • Slaughter MS, Deng M. Mechanical Circulatory Support: Chapter 10. Permanent Mechanical Circulatory Support. ISHLT Monograph Series 2006
  • Bogaev R, Hershberger R, Slaughter MS, Anderson L, Conney N. Destination Therapy Reference Guide. Thoratec Corporation, Pleasanton, CA.
  • Slaughter MS, George, T. Thoratec VAD Community Living Guide. Thoratec Corporation, Pleasanton, CA. 2004.
  • Slaughter MS, Ward HB. Surgical Management of Heart Failure. Clinics in Geriatric Medicine, 16(3):2000. Philadelphia, PA. WB Saunders Company.
Back to Top

Recently Published Articles
  • Feldman CM, Khan SN, Silver MA, Graham JD, Sobieski MA, Earhart MS, Slaughter MS. Improvement in Early Oxygen Uptake Kinetics with Left Ventricular Assist Device Support. ASAIO J. 2008.
  • Coyle LA, Martin MM, Kurien S, Graham JD, Gallagher C, Silver MA, Slaughter, MS Destination Therapy: Safety and Feasibility of National and International Travel. ASAIO J. 2008
  • Slaughter MS, Sobieski MA, Gallagher C, et al. Fibrinolytic Activation During Long-term Support With the Heartmate II Left Ventricular Assist Device. ASAIO J. 2008: Jan-Feb.
  • Sobieski MA, Graham JD, Pappas PS, Tatooles AJ, Slaughter MS Reducing the Effects of the Systemic Inflammatory Response to Cardiopulmonary Bypass: Can Single Dose Steroids Blunt SIRS? ASAIO J. 2008
  • Slaughter MS, Sobieski MA, Gallagher C, et al. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device Texas Heart Institute Journal 2008.
  • Slaughter MS, Jweied E. Managing mechanical valves with reduced anticoagulation Expert Rev. Cardiovasc. Ther. 5(6), 1073-1085 (2007)
  • Leitz K, Long JW, Kfoury AG, Slaughter MS, et al. Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era. Implications for Patient Selection. Circulation. 2007 Jul 31;116(5):497-505. Epub 2007 Jul 16.
  • Slaughter MS, Feldman CM, Sobieski MA, et al. Utilization of acoustic signatures to identify HeartMate XVE device end-of-life. J Heart Lung Transplant. 2007 Jun;26(6):579-83.
  • Slaughter MS, Tsui SS, El-Banayosy A, et al. IVAD Study Group. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg. 2007 Jun;133(6):1573-80.
  • Slaughter MS, Sobieski MA, Martin M, et al. Home Discharge Experience With the Thoratec TLC-II Portable Driver. ASAIO J. 2007 Mar-Apr;53(2):132-5.
  • Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, Sobieski M, Undar A, Farrar DJ, Koenig SC. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. J Thorac Cardiovasc Surg. 2007 Feb;133(2):517-24.
  • Feldman CM, Silver MA, Sobieski MA, Slaughter MS. Management of Aortic Insufficiency With Continuous Flow Left Ventricular Assist Devices: Bioprosthetic Valve Replacement. J Heart Lung Transplant. 2006 Dec;25(12):1410-2.
  • Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant. 2006 Jul;25(7):778-84.
  • Slaughter MS, Sobieski MA, Koenig SC, et al. Left Ventricular Assist Device Weaning: Hemodynamic Response and Relationship to Stroke Volume and Rate Reduction Protocols. ASAIO J. 2006 May-June.
Back to Top
Clinical Trials LVAD Research and Design Cardiac Device Program Consulting